Clerisy manufactures an internationally patented, FDA-approved Class 1 drug delivery platform device, that administers microencapsulated therapeutic agents through the olfactory (nasal) system by means of a simple septal strip. Worn only 2-5 minutes, the device is specifically suitable to deliver oi…
Clerisy manufactures an internationally patented, FDA-approved Class 1 drug delivery platform device, that administers microencapsulated therapeutic agents through the olfactory (nasal) system by means of a simple septal strip. Worn only 2-5 minutes, the device is specifically suitable to deliver oils & vapors of medicinal marijuana and similar all-natural therapeutic oil/vapor extracts. R & D to configure the device for systemic delivery of large active ingredients (Rx drugs; insulin, Vitamin B, etc) has commenced. The company has extensive global IP and other barriers to entry, including a Marksman Order supporting the validity and enforceability of all patent claims. The company owns the registered trademarks for Aromahaler and Nasal Soft Strips. Trademark applications are pending for Vapo-strips and "Breathe you way to a better day". Two products, Aromahaler Nasal Soft Strips for Stress Relief, and Aromahaler Nasal Soft Strips for Appetite Control recently debuted at retail. Fifteen such OTC formulations are available for the Aromahaler Brand. The Company is seeking a partner to grow/scale the company in the three strategic categories of Medicinal/Therapeutic Marijuana, OTC, and Rx delivery.
Team (1)
Sectors Clerisy Corp serves:
Life Sciences
Join Axial's Private M&A Platform
Clerisy Corp connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
